These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 19337627

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M, Savarino E, Manno M, Melotti G, Mirante VG, Mussetto A, Bertani H, Manta R, Conigliaro R.
    Aliment Pharmacol Ther; 2009 Sep 01; 30(5):508-15. PubMed ID: 19519732
    [Abstract] [Full Text] [Related]

  • 3. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ, Bredenoord AJ, Weusten BL, Monkelbaan JF, Timmer R, Smout AJ.
    Am J Gastroenterol; 2008 Oct 01; 103(10):2446-53. PubMed ID: 18684197
    [Abstract] [Full Text] [Related]

  • 4. The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.
    Pace F, Pace M.
    Expert Rev Gastroenterol Hepatol; 2010 Aug 01; 4(4):423-7. PubMed ID: 20678016
    [Abstract] [Full Text] [Related]

  • 5. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
    Savarino E, Marabotto E, Zentilin P, Frazzoni M, Sammito G, Bonfanti D, Sconfienza L, Assandri L, Gemignani L, Malesci A, Savarino V.
    Dig Liver Dis; 2011 Jul 01; 43(7):542-7. PubMed ID: 21376679
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
    Soto Pérez JC, Icaza ME, Vargas F, Valdovinos Díaz MA.
    Rev Gastroenterol Mex; 2003 Jul 01; 68(2):113-9. PubMed ID: 15127647
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.
    Viazis N, Karamanolis GP, Anastasiou J, Keyoglou A, Vlachogiannakos J, Ladas SD, Karamanolis DG.
    Eur J Gastroenterol Hepatol; 2013 Dec 01; 25(12):1450-5. PubMed ID: 24047861
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Belching: dyspepsia or gastroesophageal reflux disease?
    Lin M, Triadafilopoulos G.
    Am J Gastroenterol; 2003 Oct 01; 98(10):2139-45. PubMed ID: 14572558
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE, Chehade R, Crowell MD.
    Am J Gastroenterol; 2011 Sep 01; 106(9):1604-11. PubMed ID: 21691342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.